Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Sues Gene Logic For Patent Infringement

Premium

P

ALO ALTO, Calif.--Incyte Pharmaceuticals last month filed a patent infringement lawsuit against Gene Logic, alleging that a process used by Gene Logic for amplifying complementary DNA infringes US patents 5,716,785 and 5,891,636. Incyte also claimed that Gene Logic has infringed patent 4,981,783 in its use of cloned gene sequences as probes for expression analysis.

Saying it would contest the suit, Gene Logic contended that the first two patents relate to "very specific processes, the results of which can be easily reproduced by other methods that fall outside of those patents" and that the third has no relevance to technologies employed by its scientists. Gene Logic CEO Michael Brennan called the lawsuit an attempt by Incyte to "harass us and slow down the rapid commercial progress we are making with our launch last month of the GeneExpress database
products."

Filed under